Combination therapy for the treatment of pancreatic cancer through hyaluronic acid‐decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro study

Combination chemotherapy by means of two or more drugs is prone to suppressing or discouraging the inception of multidrug resistance, exploiting the fact that diverse drugs act in different points of the cellular cycle of amplifying tumor cells. For example, the combination of gemcitabine (GMC) with quercetin (QCT) showed a synergistic effect in inhibiting the migration of pancreatic cancer cells. Consequently, herein GMC and QCT have been loaded within biodegradable nanoparticles (NPs) based on poly(lactic‐co‐glycolic acid), externally decorated with hyaluronic acid (HA; viz., PPHA NPs), which plays a major role in drug targeting to tumors due to its ability to specifically interact with CD44 receptor, that is overexpressed in many tumors. The produced HA‐decorated NPs loaded with GMC and QCT showed an improved cytotoxicity and cellular uptake toward two cell lines of pancreatic ductal adenocarcinoma, namely Mia‐PaCa‐2 and PANC‐1, compared with both the bare drugs and the drugs loaded in NPs which do not expose HA on the surface. HA‐decorated NPs were also able to improve the anti‐inflammatory properties of QCT, therefore leading to a decrease of interleukin cellular levels in both cell lines, preliminarily stimulated with lipopolysaccharides. This result is of special interest also considering the crucial role of interleukins in progression, metastatic processes, and drug resistance of human pancreas cancer cells.

• Publication year

  2018

• Venue

  Journal of Cellular Physiology

• Publication date

  2018-10-18

• Fields of study

  Biology, Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/jcp.27297PMID 30334571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted therapies in pancreatic cancer: Promises and failures

  2018cited by this paper
• Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone‐Responsive Human Breast Cancer

  2017cited by this paper
• Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis

  2017cited by this paper
• Nano-precipitated curcumin loaded particles: effect of carrier size and drug complexation with (2-hydroxypropyl)-β-cyclodextrin on their biological performances.

  2017cited by this paper
• Surface modified zeolite‐based granulates for the sustained release of diclofenac sodium

  2017cited by this paper
• Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements

  2017cited by this paper
• Host–guest inclusion complex of quercetin and hydroxypropyl-β-cyclodextrin

  2017cited by this paper
• Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures.

  2017cited by this paper
• New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase

  2016influential reference
• CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy

  2016cited by this paper
• Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.

  2016cited by this paper
• Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles.

  2016cited by this paper
• Physicians' Cancer Chemotherapy Drug Manual

  2016cited by this paper
• Quercetin-3-O-glucoside suppresses pancreatic cancer cell migration induced by tumor-deteriorated growth factors in vitro.

  2016cited by this paper
• Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer

  2016cited by this paper
• Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy

  2016cited by this paper
• Quercetin 3-O-glucoside suppresses epidermal growth factor–induced migration by inhibiting EGFR signaling in pancreatic cancer cells

  2015cited by this paper
• Expression and significance of CD44 and p-AKT in pancreatic head cancer

  2015cited by this paper
• Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy.

  2015cited by this paper
• Tumor‐activated prodrug (TAP)‐conjugated nanoparticles with cleavable domains for safe doxorubicin delivery

  2015cited by this paper
• Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.

  2015cited by this paper
• Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.

  2014cited by this paper
• Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.

  2014cited by this paper
• Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.

  2014cited by this paper
• Effect of hyaluronic acid on the thermogelation and biocompatibility of its blends with methyl cellulose.

  2014cited by this paper
• Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures

  2013cited by this paper
• The Flavonoid Quercetin Inhibits Pancreatic Cancer Growth In Vitro and In Vivo

  2013cited by this paper
• Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

  2012cited by this paper
• Combinational therapy: new hope for pancreatic cancer?

  2012cited by this paper
• Advanced pancreatic carcinoma: current treatment and future challenges

  2010cited by this paper
• Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma

  2010cited by this paper
• Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions

  2009cited by this paper
• Synergistic drug combinations improve therapeutic selectivity

  2009cited by this paper
• [Chemotherapy for pancreatic cancer].

  2008cited by this paper
• Health effects of quercetin: from antioxidant to nutraceutical.

  2008cited by this paper
• Identification of the products of oxidation of quercetin by air oxygen at ambient temperature.

  2007cited by this paper
• Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments.

  2007cited by this paper
• Comparative evaluation of various total antioxidant capacity assays applied to phenolic compounds with the CUPRAC assay.

  2007cited by this paper
• Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes

  2004cited by this paper
• CASE REPORT: Fatal Cholestatic Liver Failure Associated with Gemcitabine Therapy

  2003cited by this paper
• Fatal cholestatic liver failure associated with gemcitabine therapy.

  2003cited by this paper
• Preclinical, pharmacologic, and phase I studies of gemcitabine.

  1997cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Phase II study of gemcitabine in patients with advanced pancreatic cancer.

  1996cited by this paper
• Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke: The Zutphen Study

  1996cited by this paper
• Chemotherapy in pancreatic cancer.

  1981cited by this paper

• Targeted cancer therapy using single- and multi-drug loaded nanoformulations: a comprehensive review.

  2026cites this paper
• A Comprehensive Overview of Quercetin: Chemistry, Analytical Approaches, Formulations, and Therapeutic Approaches

  2025cites this paper
• Targeted Gene Delivery to MCF-7 Cells via Polyspermine-PEG-Glucose/DNA Nanoparticles: Preparation and Characterization.

  2025cites this paper
• Localized paclitaxel delivery using a novel hyaluronic acid-coated fibrous carrier produced via needle-less electrospinning

  2025cites this paper
• The effect of Fe3O4 biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line

  2025influential citation
• New insights into Notch signaling as a crucial pathway of pancreatic cancer stem cell behavior by chrysin-polylactic acid-based nanocomposite

  2025cites this paper
• Design and preparation of PLA-chitosan-PEG-glucose copolymer for combined delivery of Paclitaxel and siRNA

  2025cites this paper
• Hyaluronic Acid and Its Role in Pancreatic Cancer: Mechanisms of Tumor Progression, Drug Resistance, and Therapeutic Targeting.

  2025cites this paper
• Therapeutic potentials and targeting strategies of quercetin on cancer cells: Challenges and future prospects.

  2024cites this paper
• The New Era of Pancreatic Cancer Treatment: Application of Nanotechnology Breaking Through Bottlenecks.

  2024cites this paper
• Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenvironment

  2024cites this paper
• Precision Oncology: Advances in Drug Delivery and Imaging.

  2024cites this paper
• Recent advances in drug delivery and targeting for the treatment of pancreatic cancer.

  2024cites this paper
• Therapeutic potential of flavonoids from traditional Chinese medicine in pancreatic cancer treatment

  2024cites this paper
• Solid State Synthesis of Hyaluronic Acid–Quercetin Conjugate: Sustainable Protocol to Improve the Biological Activity of Quercetin

  2024cites this paper
• Hyaluronic Acid-Based Nanoparticles Loaded with Rutin as Vasculo-Protective Tools against Anthracycline-Induced Endothelial Damages

  2024cites this paper
• Green Routes for Bio-Fabrication in Biomedical and Pharmaceutical Applications

  2023influential citation
• Hyaluronic Acid-Mediated Phenolic Compound Nanodelivery for Cancer Therapy

  2023influential citation
• Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications

  2023cites this paper
• Quercetin modulates signal transductions and targets non-coding RNAs against cancer development.

  2023cites this paper
• Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles

  2023cites this paper
• Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer

  2023cites this paper
• Potent Suppression of Prostate Cancer Cell Growth and Eradication of Cancer Stem Cells by CD44-targeted Nanoliposome-quercetin Nanoparticles

  2023cites this paper
• Chitosan and hyaluronic acid-based nanocarriers for advanced cancer therapy and intervention.

  2023cites this paper
• pH dependent biocompatible room temperature covalent organic polymers for selective chemotherapeutic drug delivery

  2023cites this paper
• Hyaluronic acid-based nanodelivery systems for food bioactive compounds

  2023cites this paper
• Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects

  2023cites this paper
• Anticancer and apoptosis inducing potential of quercetin against a wide range of human malignancies

  2023cites this paper
• Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies

  2023cites this paper
• Synergistic Anticancer Effects of Metformin and Achillea vermicularis Trin-Loaded Nanofibers on Human Pancreatic Cancer Cell Line: An In Vitro Study

  2022cites this paper
• Nano Phytoceuticals: A Step Forward in Tracking Down Paths for Therapy Against Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• A new era: tumor microenvironment in chemoresistance of pancreatic cancer.

  2022cites this paper
• Application of Quercetin in the Treatment of Gastrointestinal Cancers

  2022cites this paper
• Nanotheranostics for Image-Guided Cancer Treatment

  2022cites this paper
• Benzotriazole-oxadiazole Hybrid Compounds: Synthesis, Anticancer Activity, Molecular Docking and ADME Profiling Studies

  2022cites this paper
• Quercetin improves pancreatic cancer chemo-sensitivity by regulating oxidative-inflammatory networks.

  2022cites this paper
• Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?

  2022cites this paper
• Hyaluronic acid prodrug micelles for tumour therapy

  2021cites this paper
• Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer

  2021cites this paper
• Nanocarriers targeting the diseases of the pancreas.

  2021cites this paper
• Hyaluronan-coated nanoparticles for active tumor targeting: Influence of polysaccharide molecular weight on cell uptake.

  2021cites this paper
• Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages

  2021cites this paper
• Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects

  2021cites this paper
• A review on pharmacological activities and synergistic effect of quercetin with small molecule agents.

  2021cites this paper
• Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer

  2021cites this paper
• Advances in research of extracellular mechanisms underlying gemcitabine resistance in pancreatic cancer

  2021cites this paper
• Integrative Management of Pancreatic Cancer (PDAC): Emerging Complementary Agents and Modalities

  2021cites this paper
• Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells

  2020cites this paper
• Flavonoids in cancer therapy: current and future trends

  2020cites this paper
• Recent advances and prospects in Gemcitabine drug delivery systems.

  2020cites this paper
• Biocompatibility, Cytotoxicity, Antimicrobial and Epigenetic Effects of Novel Chitosan-Based Quercetin Nanohydrogel in Human Cancer Cells

  2020cites this paper
• Drug delivery based pharmacological enhancement and current insights of quercetin with therapeutic potential against oral diseases.

  2020cites this paper
• Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: Cancer, Diabetes, and Cardiovascular Disease

  2020cites this paper
• Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health

  2020cites this paper
• Functionalization of bismuth sulfide nanomaterials for their application in cancer theranostics

  2020cites this paper
• A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma—Toward a Better Mimicry of the in vivo Tumor Microenvironment

  2020cites this paper
• Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation

  2020cites this paper
• Drug micro-carriers with a hyaluronic acid corona toward a diffusion-limited aggregation within the vitreous body.

  2019cites this paper
• Comparative Molecular Immunological Activity of Physiological Metal Oxide Nanoparticle and its Anticancer Peptide and RNA Complexes

  2019cites this paper
• Hyaluronan-modified nanoparticles for tumor-targeting

  2019cites this paper
• Electron dispersive X-ray spectroscopy and degradation properties of hyaluronic acid decorated microparticles.

  2019cites this paper
• Quercetin Loaded Nanoparticles in Targeting Cancer: Recent Development.

  2019cites this paper
• Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis

  2018cites this paper